Search results
Results from the WOW.Com Content Network
The Suzuki Gixxer FI 150 is a 154.9 cc (9.45 cu in) naked motorcycle from Suzuki. The bike was launched in September 2014. The bike was launched in September 2014. The name derives from a nickname used in Britain and elsewhere for the GSX-R. [ 9 ]
The Suzuki GSX-R1000 (often called a Gixxer) is a sports motorcycle made by Suzuki. [1] It was introduced in 2001 to replace the GSX-R1100 and is powered by a liquid-cooled 999 cc (61.0 cu in ) inline four-cylinder , four-stroke engine although originally 988 cc (60.3 cu in) from 2001 to 2004.
Suzuki Motorcycle India, Private Limited (SMI) is the wholly owned Indian subsidiary of Suzuki, Japan. [2] It was the third Suzuki automotive venture in India, after TVS Suzuki (1982–2001) and Maruti Suzuki (1982). In 1982, the joint-venture between Suzuki Motor Corporation and TVS Motor Company incorporated and started production of two ...
Suzuki has released an up spec model GSX-R1000R; this R model comes with a Motion Track Brake System, Bi-directional quick shifter and launch control. Also on the R model, as reported by Sport Rider, are the same Showa Balance Free Front (BFF) fork and Balance Free Rear Cushion (BFRC Lite) shock that come standard on the 2016 Kawasaki ZX-10R.
The United States Food and Drugs Administration is warning pet owners about a common medication given to pets to treat arthritis. The F.D.A. now says that the drug Librela may be associated with ...
The Associated Press 2024 NFL All-Pro team selected by a national panel of 50 media members:. First team Offense. Quarterback — Lamar Jackson, Baltimore. Running Back — Saquon Barkley ...
The Suzuki GS150R is a 150cc motorcycle from Suzuki Motorcycle India. The bike was launched in November 2008. The bike was launched in November 2008. With the GS150R, Suzuki Motorcycle India entered the highly competitive 150cc segment of the Indian motorcycle market.
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release. The ...